Nanoparticulate Formulation for the Treatment of Different Types of Colon Disease Like Ulcerative Colitis: A Comprehensive Review

1Faculty of Pharmaceutical Science, Assam Down Town University, Sankar Madhab Path Gandhi Nagar, Panikhaiti, Guwahati, Assam., INDIA

2School of Pharmacy, Seacom Skills University, Bolpur, Birbhum, West Bengal, INDIA

3Eminent College Of Pharmaceutical Technology, Barasat, Jagannathpur, West Bengal, INDIA

Corresponding author.

Correspondence: Dr. Ananta Choudhury Faculty of Pharmaceutical Science, Assam Down Town University, Sankar Madhab Path Gandhi Nagar, Panikhaiti, Guwahati-781026, Assam, INDIA. Email: anantachoudhury@gmail.com
Received May 28, 2023; Revised July 10, 2023; Accepted July 28, 2023.
Copyright 2025 Authors
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

Citation

1.Ganguly D, Choudhury A, Chanda R, Das H, Mitra S, Ghosh R, et al. Nanoparticulate Formulation for the Treatment of Different Types of Colon Disease Like Ulcerative Colitis: A Comprehensive Review. Journal of Young Pharmacists [Internet]. 2023 Dec 22;15(4):585–8. Available from: http://dx.doi.org/10.5530/jyp.2023.15.82
Copy to clipboard
Published in: Journal of Young Pharmacists, 2023; 15(4): 585-588. Published online: December 07, 2023 DOI: 10.5530/jyp.2023.15.82

ABSTRACT

It is crucial to use a colon-targeted medication delivery system to treat diseases that start in the colon, such as inflammatory bowel disease, colon cancer, amoebiasis, and irritable bowel syndrome. Through colon targeted drug delivery system, we can give localised treatment to the patient which reduces the chance of toxicity and improves its therapeutic efficacy. The bioavailability of medications for the colon has greatly increased because to recent improvements in oral formulations. But because it is intimately linked to GI Inflammation, it is crucial to make some changes to the Gastrointestinal (GI) physiology to increase the therapeutic effect even more. Due to their structural makeup and smaller size, nanoparticles are often used in the administration of drugs that are specifically targeted for the colon. It is designed in such a way that it promotes aggregation time of drugs at the site of action, supporting localized therapy. This review article mainly focuses on oral nanoparticulate formulations that are targeted for treating Colon related diseases.

Keywords: Colon, Ulcerative Colitis, Nanoparticles, Drug delivery, Formulations